The softgel capsules market has seen considerable growth due to a variety of factors.
• Over the past few years, there has been a significant expansion in the market size of softgel capsules. The market is projected to rise from $8.29 billion in 2024 to $8.92 billion in 2025, with a compound annual growth rate (CAGR) of 7.7%. The past growth in the market can be attributed to factors such as rising demands in the pharmaceutical and nutraceutical sectors, customer predilection for oral dosage forms, customization and flexibility in formulation, boosted bioavailability, product differentiation, and branding strategies.
The Softgel Capsules market is expected to maintain its strong growth trajectory in upcoming years.
• Forecasted to experience significant expansion in the upcoming years, the market size for softgel capsules is projected to reach a value of $12.67 billion in 2029 with a compound annual growth rate (CAGR) of 9.2%.
The predicted growth during this forecast period can be credited to factors such as the enlargement of the healthcare industry, individualized healthcare services, growth in the functional food and beverage market, inclination towards natural and organic products, increasing focus on the senior citizens, and eco-friendly initiatives. The market trends expected to influence the industry during the forecast period encompass advances in nutraceuticals, eco-sustainability thrusts, and a preference for natural and organic products, along with regulatory compliance.
The increasingly common occurrence of chronic conditions like cardiovascular diseases is anticipated to fuel the expansion of the soft gel capsules market. Chronic conditions are long-lasting illnesses that persist for at least a year, including diseases such as cancer, heart disease, stroke, diabetes, and arthritis. These widespread chronic conditions can be managed but not fully cured, requiring consistent nutritional and medical intervention. Soft gel capsules supply the necessary nutritional supplements for patients suffering from these chronic conditions, thus, the growing prevalence of such diseases escalates the demand for soft gel capsules. For instance, a study published in September 2022 by the Indian Council of Medical Research, a leading body for biomedical research in India, and the Registrar General and Census Commissioner of India, a governmental agency responsible for registration activities throughout the nation, revealed that approximately 60% of the worldwide heart disease burden can be traced back to India. On World Heart Day 2022, close to 17.9 million lives globally were reported lost to cardiovascular diseases (CVDs), which are the primary cause of deaths worldwide. Hence, the escalating occurrence of chronic conditions like cardiovascular diseases is expected to drive the growth of the soft gel capsules market.
The softgel capsules market covered in this report is segmented –
1) By Type: Gelatin Or Animal Based, Non-Animal Based
2) By Manufacturers: Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies, Contract Manufacturing Organizations, Softgel Capsules
3) By Application: Antacid And Anti-Flatulent Preparations, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic And Antibacterial Drugs, Cough And Cold Preparations, Health Supplement, Vitamin And Dietary Supplement, Pregnancy
Subsegments:
1) By Gelatin Or Animal Based: Porcine Gelatin, Bovine Gelatin, Fish Gelatin
2) By Non-Animal Based: Vegetarian Capsules, Gelatin Alternatives
Innovations in technology are an emerging trend in the softgel capsules market, capturing significant attention. The key players in the softgel capsules industry are keen on creating novel products using the most recent technologies to maintain their market standing. A case in point, International Flavors & Fragrances (IFF), Inc., an American company that manufactures flavors, fragrances, and cosmetic actives, announced in April 2023, the launch of VERDIGEL SC, a new pectin-based enhancement that will expand its vegan softgel collection. VERDIGEL SC ushers in a revolutionary, carrageenan-free, vegan softgel technology. This premix, based on pectin, guarantees premium softgel quality, effectiveness, and process efficacy. It has been constructed for seamless integration with existing operations and needs only water and a plasticizer to create high-performance softgels, making it apt for a multitude of formulations.
Major companies operating in the softgel capsules market include:
• Catalent Inc.
• Eurocaps Ltd.
• Aenova Group GmbH
• Sirio Pharma Co. Ltd.
• Procaps Laboratories Inc.
• Captek Softgel International Inc.
• Fuji Capsule Co. Ltd.
• Hunan ER-KANG Pharmaceutical Co. Ltd.
• Curtis Health Caps SA
• Delpharm Holding SAS
• Estrellas Life Sciences Pvt. Ltd.
• Elnova Pharma LLP
• Soft Gel Technologies Inc.
• Weihai Baihe Biology Technological Co. Ltd.
• United Laboratories
• Robinson Pharma Inc.
• Thermo Fisher Scientific Inc.
• Best Formulations Inc.
• DCC PLC
• Biophar Lifesciences Pvt. Ltd.
• Swisschem Healthcare
• Krishlar Pharmaceuticals
• Amzor Healthcare Pvt. Ltd.
• Medgel Pvt. Ltd.
• Amway Corp.
• Welex Laboratories Pvt. Ltd.
• NutraScience Labs Inc.
• Nutrifynn Caps Inc.
• NutraPak USA
• Nutrafill LLC
• Nutricap Labs LLC
• Nutra Manufacturing Inc.
• Ion Labs Inc.
• Vitakem Nutraceutical Inc.
• Private Label Nutraceuticals LLC
• NutraLab Canada Ltd.
• Makers Nutrition LLC
North America was the largest region in the soft gel capsules market in 2024. The regions covered in the softgel capsules market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.